ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD(®)) in Asian men with prostate cancer
ELIGANT：一项针对亚洲前列腺癌男性患者的醋酸亮丙瑞林（ELIGARD®）的4期干预性安全性研究
期刊:Translational Andrology and Urology
影响因子:1.7
doi:10.21037/tau-21-723
Malek, Rohan; Wu, Sheng-Tang; Serrano, Dennis; Tho, Tran; Umbas, Rainy; Teoh, Jeremy; Lojanapiwat, Bannakji; Ong, Teng Aik; On, Weber Kam; Thai, Sam Minh; Kim, Janet; Pophale, Rupesh; Chiong, Edmund
